.
.
MEDICAL: DISEASES: EBOLA VIRUS :
AFRICA :
INDUSTRIES: PHARMACEUTICAL:
Ebola Outbreak: Why Has 'Big Pharma' Failed Deadly Virus' Victims?
.
.
Ebola Outbreak: Why Has 'Big Pharma' Failed Deadly Virus' Victims?
Because, says a leading scientist, there was 'no business case' for a
vaccine
Charlie Cooper
Sunday 07 September 2014
The Independent
http://www.independent.co.uk/life-style/health-and-families/
health-news/ebola-outbreak-big-pharma-failed-victims-why-9716615.html
.
A shorter URL for the above link:
.
http://tinyurl.com/mu7eunc
.
.
The scientist leading Britain's response to the Ebola pandemic has
launched a devastating attack on "Big Pharma", accusing drugs giants
including GlaxoSmithKline (GSK), Sanofi, Merck and Pfizer of failing to
manufacture a vaccine, not because it was impossible, but because there
was "no business case".
.
West Africa's Ebola outbreak, which has now claimed well over 2,000 lives,
could have been "nipped in the bud", if a vaccine had been developed and
stockpiled sooner a feat that would likely have been "do-able", said
Professor Adrian Hill of Oxford University.
.
A team led by Professor Hill is to begin trials of an experimental Ebola
vaccine fast-tracked into development in a desperate bid to slow the
spread of the virus in Guinea, Sierra Leone and Liberia. If it passes
safety and effectiveness trials, 10,000 doses of the vaccine co-developed
by the Britain's GSK and America's National Institutes of Health (NIH)
could be used to protect health workers in West Africa by December.
.
However, Professor Hill said that the fact that a vaccine had not been
available to stop the disease when it emerged in Guinea six months ago
represented a "market failure" of the commercial system of vaccine
production which is dominated by the pharmaceutical giants.
.
The scale of the Ebola outbreak and the devastation it is causing in terms
of lives lost and social breakdown had led the World Health Organisation
(WHO) to order an unprecedented acceleration of normal drug development
processes.
.
Experts are looking at 10 different unlicensed and experimental Ebola
therapy and vaccine candidates, of which the GSK/NIH vaccine is among the
most promising. Regulatory processes that usually take up to 15 years have
been abandoned, to fast-track drugs and vaccines into the field.
.
Already, the experimental drug ZMapp, developed by Mapp, a small
biopharmaceutical firm in the US, has been used to treat at least seven
patients four of them Westerners and has shown promising results in
trials on primates. Stocks have now run out, but Mapp has been handed $25m
(15m) by the US government to scale up production.
.
On Friday, the WHO met in Geneva to assess the options but concluded that
despite the extraordinary measures, "new treatments or vaccines are not
expected for widespread use before the end of 2014".
.
.
The complete article may be read at the URL above.
.
.
Sincerely,
David Dillard
Temple University
(215) 204 - 4584
[log in to unmask]
http://workface.com/e/daviddillard
Net-Gold
http://groups.yahoo.com/group/net-gold
http://listserv.temple.edu/archives/net-gold.html
General Internet & Print Resources
http://tinyurl.com/pwyg37u
COUNTRIES
http://tinyurl.com/p7s2z4u
EMPLOYMENT
http://tinyurl.com/oxa9w52
TOURISM
http://tinyurl.com/pnla2o9
DISABILITIES
http://tinyurl.com/pl7gorq
INDOOR GARDENING
http://tech.groups.yahoo.com/group/IndoorGardeningUrban/
Educator-Gold
http://groups.yahoo.com/group/Educator-Gold/
K12ADMINLIFE
http://groups.yahoo.com/group/K12AdminLIFE/
The Russell Conwell Learning Center Research Guide:
THE COLLEGE LEARNING CENTER
http://tinyurl.com/obcj6rf
Information Literacy
http://tinyurl.com/78a4shn
Research Guides
https://sites.google.com/site/researchguidesonsites/
Nina Dillard's Photographs on Net-Gold
http://tinyurl.com/36qd2o
and also at
http://www.flickr.com/photos/neemers/
Twitter: davidpdillard
Temple University Site Map
https://sites.google.com/site/templeunivsitemap/home
Bushell, R. & Sheldon, P. (eds),
Wellness and Tourism: Mind, Body, Spirit,
Place, New York: Cognizant Communication Books.
Wellness Tourism: Bibliographic and Webliographic Essay
David P. Dillard
http://tinyurl.com/p63whl
RailTram Discussion Group
From the Union Pacific to BritRail and Beyond
https://groups.yahoo.com/neo/groups/railtram/info
INDOOR GARDENING
Improve Your Chances for Indoor Gardening Success
http://tech.groups.yahoo.com/group/IndoorGardeningUrban/
SPORT-MED
https://www.jiscmail.ac.uk/lists/sport-med.html
http://groups.yahoo.com/group/sports-med/
http://listserv.temple.edu/archives/sport-med.html
HEALTH DIET FITNESS RECREATION SPORTS TOURISM
http://health.groups.yahoo.com/group/healthrecsport/
http://listserv.temple.edu/archives/health-recreation-sports-tourism.html
.
.
Please Ignore All Links to JIGLU
in search results for Net-Gold and related lists.
The Net-Gold relationship with JIGLU has
been terminated by JIGLU and these are dead links.
http://groups.yahoo.com/group/Net-Gold/message/30664
http://health.groups.yahoo.com/group/healthrecsport/message/145
Temple University Listserv Alert :
Years 2009 and 2010 Eliminated from Archives
https://sites.google.com/site/templeuniversitylistservalert/
.
.
|